Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
about
Abnormal kalirin signaling in neuropsychiatric disorders.The choreography of neuroinflammation in Huntington's diseaseMouse models of polyglutamine diseases: review and data table. Part ILifelong bilingualism and neural reserve against Alzheimer's disease: a review of findings and potential mechanismsPhysical exercise-induced adult neurogenesis: a good strategy to prevent cognitive decline in neurodegenerative diseases?Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolismEnvironmental enrichment and brain repair: harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticityMetabolism in HD: still a relevant mechanism?A new use for long-term frozen brain tissue: golgi impregnation.Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice.Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease.Dual regulation of dendritic morphogenesis in Drosophila by the COP9 signalosome.COP9 limits dendritic branching via Cullin3-dependent degradation of the actin-crosslinking BTB-domain protein Kelch.Lack of riluzole efficacy in the progression of the neurodegenerative phenotype in a new conditional mouse model of striatal degeneration.Spatiotemporal maturation patterns of murine brain quantified by diffusion tensor MRI and deformation-based morphometry.Synapse density and dendritic complexity are reduced in the prefrontal cortex following seven days of forced abstinence from cocaine self-administrationIn vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegenerationGenetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients.BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 miceStandardized environmental enrichment supports enhanced brain plasticity in healthy rats and prevents cognitive impairment in epileptic rats.Dendritic spine dynamics--a key role for kalirin-7.SORLA-mediated trafficking of TrkB enhances the response of neurons to BDNF.Epigenetic regulation of neuronal dendrite and dendritic spine developmentDifferential Changes in Postsynaptic Density Proteins in Postmortem Huntington's Disease and Parkinson's Disease Human Brains.CAG repeat lengths > or =335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse.Optimising Golgi-Cox staining for use with perfusion-fixed brain tissue validated in the zQ175 mouse model of Huntington's disease.Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington's diseasemiR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington's Disease Monkey Neural CellsNovel therapeutic targets for Huntington's disease.Abnormalities in synaptic dynamics during development in a mouse model of spinocerebellar ataxia type 1.A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington's diseaseHow does environmental enrichment reduce repetitive motor behaviors? Neuronal activation and dendritic morphology in the indirect basal ganglia pathway of a mouse model.The corticostriatal pathway in Huntington's disease.Enviromimetics: exploring gene environment interactions to identify therapeutic targets for brain disorders.A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's diseaseRanBP9 overexpression reduces dendritic arbor and spine density.Huntington's disease: can mice lead the way to treatment?Kalirin signaling: implications for synaptic pathology.Kalirin, a key player in synapse formation, is implicated in human diseases.
P2860
Q26824648-060BE84D-9FE1-48CF-9079-EFA77CB6ABEAQ26828403-889C2BB2-6894-4999-8F3F-31A79CDED147Q26853025-527F7D87-CB40-491C-A258-9BC8A2BACBF0Q27008544-5D786CFB-EA2F-4660-96BE-CC56E1AC634CQ27012489-135B5B36-FC2F-4C3E-9C50-5923EF6A8947Q27309160-D33A8648-943B-4A35-A85D-9DC67AC57A61Q28304384-31889672-75E0-487B-BD0A-D0214FB3DDC1Q28394301-2D63875F-9DA3-4C32-9FFB-13EE84287FDCQ30483716-64F4F327-160A-437A-8209-54932AAF76FCQ30588621-5AED84EA-3D75-4CC7-9DB2-C051812E480EQ33326475-C210FFE4-4EB5-4307-80E2-EB3534783D0AQ33512518-CB7D46E2-64EC-4535-AC3F-054F87B0275DQ33512913-07508D7D-00EF-4071-9A2A-7914FC51374EQ33618095-51C501F8-E255-4852-B5A4-559E728E30F4Q33784240-14CC5219-6FB0-4165-A292-FFFE8E55E17AQ33966766-C7CD0B59-652C-470C-8CC1-6960093B22D9Q34050850-CF9E3C37-1EF5-4094-BB8D-EBB7B74C365DQ34312581-4E35A1A1-35C4-4E80-810D-BF2B2DE395B2Q34338809-D78E0C78-F9FD-4DC0-B6F7-6BAB1056F334Q34558891-1F03F8B4-DF28-487A-8A77-68B327D295E8Q34791771-E37072D0-7DD3-4316-A9BF-4C2D72117482Q34973554-D6BFEC21-17D9-4E97-B6DC-B08502C226F1Q35018423-B5755CCE-628A-4558-8B35-11E4277D0A75Q35623502-11122162-8B6B-48AB-9217-A04B01F491AEQ35703870-2D1169F4-4BF2-415F-B05D-56FB420663EEQ35803888-2EDA0D1B-8810-4883-95AA-B913785DBEB2Q36088666-4230FD41-8E17-4CD5-AAB2-1422F058E20DQ36133682-619842F6-6257-4A80-BBC0-3035E2D4C2F6Q36219680-B3233842-58E9-4767-8A83-A9C9FFF99E8AQ36245783-BA039FE3-982D-4971-B29C-847861712710Q36331582-304A24C8-AD31-406E-B749-30E2D264BE4EQ36418479-FECBD832-6B68-4F57-B32D-061DDB8846ABQ36684263-17DA27CE-28F5-4823-BE14-9A5DAFAFF7A9Q36871981-ED109DF0-C399-4E1D-AD47-B45E6499F6B4Q37345118-FCAE90B6-8E6B-4116-9830-6B7677F9ED0AQ37456285-22727244-E7A8-40A9-901D-AE093DDF6982Q37678635-1769AE0A-FBE6-4AB5-9C13-C74048C7E629Q37840353-ECD7612F-4EDA-4F9B-A4C5-2E5E9451E46BQ37970980-AB15D6C6-A352-4729-B1FF-04F43F64915FQ38006709-DF884816-C900-4C2F-8BBA-361F915FB944
P2860
Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Dendritic spine pathology and ...... ton's disease transgenic mice.
@en
Dendritic spine pathology and ...... ton's disease transgenic mice.
@nl
type
label
Dendritic spine pathology and ...... ton's disease transgenic mice.
@en
Dendritic spine pathology and ...... ton's disease transgenic mice.
@nl
prefLabel
Dendritic spine pathology and ...... ton's disease transgenic mice.
@en
Dendritic spine pathology and ...... ton's disease transgenic mice.
@nl
P2093
P2860
P1476
Dendritic spine pathology and ...... ton's disease transgenic mice.
@en
P2093
Anton Van Dellen
Colin Blakemore
Helen E Grote
Patricia M Cordery
Sylvia Garry
P2860
P304
P356
10.1111/J.0953-816X.2004.03374.X
P407
P577
2004-05-01T00:00:00Z